Practical Cardiology

Initial Treatment and Cost of Care in Pulmonary HypertensionA new study finds that the first treatment chosen to treat PAH may help mitigate the burden of all-cause cost of care.
Breast Cancer, Chemotherapy, & HF: The Long-term Effects of EpirubicinHow do the benefits of epirubicin against breast cancer stack up against the risk of late-onset heart failure?
Measuring Nonfasting LDL-C: A Formula for the Future?Will results of a study comparing a new formula for evaluating LDL-C in the nonfasting state and the Friedewald method turn heads?
ECG Features Predict 30-day Arrhythmias in Older Adults with SyncopeA new study identified 6 ECG features that warn of potentially fatal cardiac arrhythmia in adults presenting with syncope.
The Benefits of IndapamideMore potent than hydrochlorothiazide to treat hypertension, this non-thiazide diuretic deserves a closer look.
Apolipoprotein(a): What Role in Atrial Fibrillation?Is elevated Lp(a) a risk factor for ischemic stroke in persons with atrial fibrillation? Results of this ARIC analysis explain.
Chlorthalidone: Under-appreciated, Under-utilized, UndervaluedChlorthalidone is one of the "Rodney Dangerfield" diuretics in the treatment of hypertension. That needs to change.
2017 ACC/AHA Hypertension Guidelines: The TakeawaysClick through our topline review of the key takeaways from this long-awaited update.
The Top 5 Biomarkers in Cardiovascular Disease PreventionWhich biomarker is most useful in what situation? Find out how one cardiologist makes these decisions. Do you concur?
PCSK9 Inhibitors: A 5-Question QuizThe PCSK9 inhibitor class is here to stay. Find out what you know about the enzyme and how its inhibition is revolutionizing CHD prevention.